OncoSec Medical Inc (ONCSQ)

[Titan V]

I expect an offering around July-August. IMO it will come after the drug supply partnership news for sure, which may or may not lift the PPS (depends on the contents of the PR - comments from Merck (validation) and/or exclusivity language).

Not sure how likely it is, but there is a chance IMO, that the 2017 milestone that says "Secure licensing or commercial partnership(s)" refers to an ex-US partnership in an indication other than melanoma. Recall Punit mentioning in recent presentations (few months ago) that a significant licensing deal on the current lead program will not happen until 2018, and also that the registration trial does not preclude them from doing ex-US collaborations. So what's this 2017 licensing/commercial partnership milestone indicating? I personally think we could see a collaboration, with upfront cash (since for this one it does not specify "drug supply agreement"), with someone like Roche on TNBC or head and neck cancer. OncoSec could really do its investor base a favor for their loyalty by doing the raise after this potential milestone.

One might say the current TNBC trial is only in phase 1 with 10 patients. I don't think it would be a factor. For example in 2014, Roche bought a company (a 1 year old spinoff) for $1.7B with a phase 1 breast cancer trial. I don't think it is unreasonable to expect a partnership this early.
http://www.pmlive.com/pharma_news/roche_makes_$1.7bn_oncology_acquisition_581862